- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Complement receptor 1 (CR1), also known as CD35, is a cell surface glycoprotein involved in immune complex clearance and complement regulation. CD35 Antibody / CR1 Complement Receptor 1 Antibody is widely used to study immune system organization, particularly within lymphoid tissues where CD35 plays a key role in antigen presentation and complement-mediated immune responses. CD35 antibody, also referred to as CR1 antibody in the literature, is an important tool for evaluating follicular dendritic cell networks and immune complex handling. This antibody is part of a collection of Human Protein Microarray validated antibodies that have been screened for specificity across thousands of proteins.
CD35 is expressed on several cell types including erythrocytes, B cells, monocytes, and most prominently follicular dendritic cells within lymphoid follicles. Its primary function is to bind complement components such as C3b and C4b, facilitating clearance of immune complexes and regulation of complement activation. This activity is critical for maintaining immune homeostasis and preventing excessive inflammatory responses.
In immunohistochemistry, CD35 is most characteristically observed as a mesh-like staining pattern corresponding to follicular dendritic cell networks within germinal centers. This distinctive distribution makes CD35 antibody particularly useful for identifying follicular architecture in tissues such as tonsil, lymph node, and spleen. The ability to visualize these networks provides important context for studies of lymphoid organization, B-cell maturation, and germinal center dynamics.
Functionally, CD35 plays a central role in adaptive immunity by retaining immune complexes on follicular dendritic cells, allowing prolonged antigen presentation to B cells. This process supports affinity maturation and antibody production. Disruption of CD35 function has been associated with immune dysregulation and altered complement activity, highlighting its importance in both normal and disease states.
In pathology, CD35 expression is frequently evaluated in lymphoid tissues and tumors, particularly in the assessment of follicular dendritic cell networks and related neoplasms. Immunohistochemical staining using CD35 antibody can help distinguish lymphoid architecture and identify follicular dendritic cell-derived tumors, as well as provide insight into tumor microenvironment organization.
The mouse monoclonal clone CR1/6378 antibody provides reliable detection of CD35 in immunohistochemistry applications. Its ability to clearly delineate follicular dendritic cell networks in lymphoid tissues makes it well suited for studies of immune structure, complement biology, and lymphoid tissue organization.
This CD35 antibody is part of a broader CD antibody panel offered by NSJ Bioreagents.
Optimal dilution of the CD35 Antibody / CR1 Complement Receptor 1 Antibody should be determined by the researcher.
A portion of amino acids 650-850 was used as the immunogen for the CD35 antibody.
Aliquot the CD35 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
CR1 antibody, Complement receptor 1 antibody, CD35 protein antibody, Immune complex receptor antibody, Erythrocyte CR1 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.